Kenvue, Boehringer, Haleon fined in Belgium for coordinating on drug placement (corrects*)
MLex Summary: Kenvue, Boehringer Ingelheim and Haleon have been fined 11.2 million euros in Belgium for illegally coordinating on a “category management arrangement,” where they jointly decided which over-the-counter medicines should...To view the full article, register now.
Already a subscriber? Click here to view full article